Características demográficas actuales del virus de la hepatitis C

Estimating future hepatitis C morbidity, mortality, and costs in the United States. American Journal of Public Health. ,vol. 90, pp. 1562- 1569 ,(2000) , 10.2105/AJPH.90.10.1562

Eric Chak, Andrew H. Talal, Kenneth E. Sherman, Eugene R. Schiff, Sammy Saab, Hepatitis C virus infection in USA: an estimate of true prevalence Liver International. ,vol. 31, pp. 1090- 1101 ,(2011) , 10.1111/J.1478-3231.2011.02494.X

D. Lavanchy, Evolving epidemiology of hepatitis C virus Clinical Microbiology and Infection. ,vol. 17, pp. 107- 115 ,(2011) , 10.1111/J.1469-0691.2010.03432.X

David Kershenobich, Homie A. Razavi, Curtis L. Cooper, Alfredo Alberti, Geoffrey M. Dusheiko, Stanislas Pol, Eli Zuckerman, Kazuhiko Koike, Kwang-Hyub Han, Carolyn M. Wallace, Stefan Zeuzem, Francesco Negro, Applying a system approach to forecast the total hepatitis C virus‐infected population size: model validation using US data Liver International. ,vol. 31, pp. 4- 17 ,(2011) , 10.1111/J.1478-3231.2011.02535.X

James A. Morrill, Melissa Shrestha, Richard W. Grant, Barriers to the treatment of hepatitis C : Patient, provider, and system factors Journal of General Internal Medicine. ,vol. 20, pp. 754- 758 ,(2005) , 10.1111/J.1525-1497.2005.0161.X

Savino Bruno, Massimo Zuin, Andrea Crosignani, Sonia Rossi, Felice Zadra, Luigi Roffi, Mauro Borzio, Alessandro Redaelli, Alberto Chiesa, Enrico Maria Silini, Piero Luigi Almasio, Patrick Maisonneuve, Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. The American Journal of Gastroenterology. ,vol. 104, pp. 1147- 1158 ,(2009) , 10.1038/AJG.2009.31

J. Paul Leigh, Christopher L. Bowlus, Bruce N. Leistikow, Marc Schenker, Costs of Hepatitis C Archives of Internal Medicine. ,vol. 161, pp. 2231- 2237 ,(2001) , 10.1001/ARCHINTE.161.18.2231

Fan-Chen Tseng, Thomas R. O'Brien, Mingdong Zhang, Alex H. Kral, Betty A. Ortiz-Conde, Jennifer Lorvick, Michael P. Busch, Brian R. Edlin, Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000 Hepatology. ,vol. 46, pp. 666- 671 ,(2007) , 10.1002/HEP.21765

Savino Bruno, Tommaso Stroffolini, Massimo Colombo, Simona Bollani, Luisa Benvegnù, Giuseppe Mazzella, Antonio Ascione, Teresa Santantonio, Felice Piccinino, Pietro Andreone, Alessandra Mangia, Giovanni B. Gaeta, Marcello Persico, Stefano Fagiuoli, Piero L. Almasio, , Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study Hepatology. ,vol. 45, pp. 579- 587 ,(2007) , 10.1002/HEP.21492

Joseph F. Perz, Gregory L. Armstrong, Leigh A. Farrington, Yvan J.F. Hutin, Beth P. Bell, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide Journal of Hepatology. ,vol. 45, pp. 529- 538 ,(2006) , 10.1016/J.JHEP.2006.05.013